WIM

Woodford Investment Management Portfolio holdings

AUM $310M
1-Year Return 17.41%
This Quarter Return
-4.65%
1 Year Return
-17.41%
3 Year Return
-27.69%
5 Year Return
+67.02%
10 Year Return
–
AUM
$1.12B
AUM Growth
-$359M
Cap. Flow
-$319M
Cap. Flow %
-28.37%
Top 10 Hldgs %
100%
Holding
8
New
2
Increased
2
Reduced
2
Closed
2

Top Buys

1
EVFM
Evofem Biosciences, Inc. Common Stock
EVFM
+$47.4M
2
NCNA
NuCana
NCNA
+$6.24M
3
TBPH icon
Theravance Biopharma
TBPH
+$3.68M
4
PRTA icon
Prothena Corp
PRTA
+$1.06M

Top Sells

1
ALKS icon
Alkermes
ALKS
+$134M
2
GILD icon
Gilead Sciences
GILD
+$113M
3
BIVV
Bioverativ Inc. Common Stock
BIVV
+$105M
4
BIIB icon
Biogen
BIIB
+$24.9M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
PRTA icon
1
Prothena Corp
PRTA
$439M
$424M 37.74%
11,557,614
+29,000
+0.3% +$1.06M
ALKS icon
2
Alkermes
ALKS
$4.52B
$305M 27.17%
5,270,428
-2,315,255
-31% -$134M
TBPH icon
3
Theravance Biopharma
TBPH
$699M
$264M 23.51%
10,898,879
+151,771
+1% +$3.68M
BIIB icon
4
Biogen
BIIB
$21.1B
$76.6M 6.81%
279,564
-91,000
-25% -$24.9M
EVFM
5
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$47.4M 4.22%
+497,703
New +$47.4M
NCNA
6
NuCana
NCNA
$8.43M
$6.24M 0.56%
+66
New +$6.24M
GILD icon
7
Gilead Sciences
GILD
$138B
– –
-1,579,353
Closed -$113M
BIVV
8
DELISTED
Bioverativ Inc. Common Stock
BIVV
– –
-1,948,325
Closed -$105M